Clinical Trials Browser

Phase 3 × OTHER × Ameloblastoma × Clear all

NCT06264778 2024-02-20

Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma

Phase 3 Unknown

Ameloblastoma